Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
NCT06325423
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Muscle-Invasive Bladder Carcinoma
Interventions
COMBINATION_PRODUCT:
neoadjuvant chemotherapy
Sponsor
Assiut University